Bharat Dixit
Chief Technology Officer Adiso Therapeutics
Bharat Dixit is the Chief Technology Officer at Adiso Therapeutics, bringing a wealth of experience in the microbiome industry. For over 15 years, he has been at the forefront of analytical, process development and manufacturing of complex biologics including LBPs.
He has collaborated with numerous CDMOs across the globe, gaining a comprehensive understanding of the technical and operational complexities in outsourcing and manufacturing.
A returning speaker at Hanson Wade’s microbiome conferences, Bharat brings a unique perspective informed by extensive industry experience, offering valuable insights into the field’s evolution, current challenges, and future opportunities.
Seminars
Wednesday 11th November 2026
Chair’s Opening Remarks
8:25 am
Wednesday 11th November 2026
Panel Discussion; Optimizing LBP & FMT Commercialization Models to Identifying Sustainable Microbiome Growth Strategies
8:30 am
- Evaluating consumer commercialization approaches to identifying scalable market adoption strategies for LBP & FMT developers
- Assessing reimbursement-driven therapeutic models to determining long-term revenue generation opportunities across microbiome markets
- Identifying customer engagement techniques to strengthening awareness, retention & downstream therapeutic demand
Wednesday 11th November 2026
Panel Discussion: Sharing Regulatory Navigation Strategies Across Global Agencies to Reduce Uncertainty & Accelerate Clinical Progression
1:30 pm
- Benchmarking regulatory pathways used across FDA, EMA & national authorities to clarify expectations and reduce trial approval uncertainty
- Comparing real-world regulatory interactions including key questions, feedback loops & submission strategies to strengthen future applications
- Identifying common pitfalls in CMC, trial design & product characterisation to proactively mitigate delays in regulatory approval processes
Wednesday 11th November 2026
Chair’s Closing Remarks
5:15 pm
